Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Other 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Overweight 1Obesity 1Neoplasm Metastasis 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Diet, Plant-Based × 1 year × Clear all
NCT07189702 2026-04-08

BEND-MBEC

University of Rochester

Phase NA Not yet recruiting
60 enrolled
Gynecologic

Neoplasm Metastasis, Endometrial Neoplasms

NCT05471414 2026-01-22

WFPBD

Weill Medical College of Cornell University

Phase NA Active not recruiting
76 enrolled
Genitourinary

Prostatic Neoplasms

NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT04298086 2025-07-11

A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
43 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡